CHICAGO, Jan. 30, 2025 /PRNewswire/ -- Conagra Brands, Inc. (NYSE: CAG) will present at the 2025 CAGNY (Consumer Analyst Group of New York) Conference on Tuesday, Feb. 18, at 9 a.m. ET.  Sean Connolly, president and chief executive officer of Conagra Brands, Dave Marberger, executive vice president and chief financial officer, and Bob Nolan, senior vice president of demand science, will present information on Conagra Brands' business strategies and financial outlook.  A video webcast of the presentation and ...

Total of $100,000 Awarded to Five Patient Advocacy Organizationsto Support Communications and Community Outreach SOUTH SAN FRANCISCO, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its seventh annual Communications Grant Program, intended to support increased communications, awareness building and community engagement. Five grants in the amount of $20,000 each were awarded this year to patient advocacy organizations serving the hypertrop ...

Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposium Eight abstracts discussing data and clinical experience associated with MIPLYFFA accepted for poster presentation, with one poster selected for oral presentation by Dr. Eugen Mengel CELEBRATION, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that eight abstracts discussing data and clinica ...

VANCOUVER, British Columbia, Jan. 30, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone-as-a-Service (DaaS), enterprise SaaS and Quantum Computing solutions, announces that its subsidiaries ZenaDrone and Spider Vision Sensors are collaborating with Taiwan-based certified electronics manufacturer and partner, Suntek Global, to apply for the company’s first Blue UAS (Unmanned Aerial System) ...

It was about a year ago that shares of Iovance Biotherapeutics (IOVA -1.94%) began to take off. The stock soared on news of approval from the Food and Drug Administration for Amtagvi (lifileucel) as a treatment option for patients with unresectable or metastatic melanoma.Since hitting a high of more than $18 last February, however, the stock has been declining steadily. And over the past six months, it has fallen by 32%. Entering trading this week, shares of Iovance are worth a little over $6 -- just a frac ...

MIAMI, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Watsco, Inc. (NYSE: WSO) announced today that it has scheduled a conference call to discuss its 2024 fourth quarter performance and annual results on Tuesday, February 18, 2025 at 10:00 a.m. (ET). Prepared remarks regarding the results will be followed by a question-and-answer session with the senior management team. The conference call will be web-cast by CCBN's StreetEvents and can be found under the link highlighted on our website at www.watsco.com. The earnings r ...

SANDUSKY, Ohio, Jan. 30, 2025 /PRNewswire/ -- Civista Bancshares, Inc. (NASDAQ:CIVB) ("Civista") announced its unaudited financial results for the three- and twelve-month periods ending December 31, 2024.Fourth quarter and full-year 2024 highlights: Net income of $9.9 million, or $0.63 per diluted share, for the fourth quarter of 2024, compared to $9.7 million, or $0.62 per diluted share, for the fourth quarter of 2023. Net income of $31.7 million, or $2.01 per diluted share, compared to $43.0 million, or $ ...

TROY, Mich., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Kelly, a leading global specialty talent solutions provider, will release its fourth-quarter and full-year earnings before the market opens on Thursday, February 13, 2025. In conjunction with its earnings release, Kelly will publish a financial presentation and host a live webcast of a conference call with financial analysts at 9 a.m. ET on February 13 to review the results from the quarter and answer questions. The presentation and a link to the live webcast w ...

NEW HAVEN, Conn., Jan. 30, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of patients with chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC), today announced that senior management will be attending the following investor conferences in February.Piper Sandler Biopharma Mogul SummitFebruary 2-4, 2025, Park City, UtahTrevi Repres ...

WASHINGTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024 before the New York market opens on Thursday, February 20, 2025. A conference call will be held to discuss these financial results on Thursday, February 20, 2025, at 9:00 a.m. Eastern Time and will be hosted by senior management. The conference call will be simulcast live on the Internet and can be accessed by loggi ...